Allergy Therapeutics (AGY.LSE) Q1 2024 Earnings

27MarConfirmed
Mar 22
Sep 22
Q2 2023
Q1 2024
-2
-1.33
-0.66
0.01

Details

Expected EPS
0
Actual EPS
-0.5851899406361208
Surprise EPS
-0.59
Surprise Percent
+∞%

Description

Allergy Therapeutics (AGY.LSE) has reported earnings of -0.5851899406361208 per share for Q1 2024.

0 Comments

Share your thoughts